NCT02051790View on ClinicalTrials.gov

Evaluation of Reader Training Processes

PHASE4CompletedINTERVENTIONAL
Enrollment

241

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions
Alzheimer's Disease
Interventions
DRUG

florbetapir F 18

No study drug will be administered in this study - scans previously acquired in the course of clinical practice.

Trial Locations (1)

19104

Research Site, Philadelphia

Sponsors
All Listed Sponsors
lead

Avid Radiopharmaceuticals

INDUSTRY